Industrial Technology Research Institute

Meng-Nan Lin

Kuo-Kuei Huang

Pei-Hsin Lin

I-Horng Pan

Yi-Cheng Cheng

Jennline Sheu

Pei-Ru Liau

Hui-Ping Tsai

Lain-Tze Lee

Chu-Hsun Lu

I-Hong Pan

Jir-Mehng Lo

Shu-Fang Wen

Chih-Peng Liu

Zong-Keng Kuo

Ying-Chu Shih

Tsan-Lin Hu

Maggie Lu

Felice Cheng

I-Huang Lu

Chia-Ching Chen

Shao-Chan Yin

Yen-Jen Wang

Chien-Lin Pan

Wen-Chia Huang

Tze-Chung Lee

Ya-Yan Yang

Jia-Horng Liaw

Wan-Chun Liu

Tze- Chung Lee

A method of treating or alleviating autoimmune-related diseases is provided. The method includes administering a pharmaceutical composition to a subject in need thereof. Moreover, the pharmaceutical composition includes an extract of-as an effective ingredient and a pharmaceutically acceptable carrier or salt.

Method for treating or alleviating autoimmune-related diseases

A composition for improving the solubility of poorly soluble substances is provided. The composition includes about 40-99.5% by weight of cyclodextrin and/or derivatives thereof; about 0.05-10% by weight of at least one water-soluble polymer; and about 0.05-60% by weight of at least one water-soluble stabilizer.

Composition for improving the solubility of poorly soluble substances, use thereof and complex formulation containing thereof

A method of treating or alleviating autoimmune-related diseases is provided. The method comprises administering a pharmaceutical composition to a subject in need thereof. Moreover, the pharmaceutical composition comprises an extract of Amomum tsao-ko as an effective ingredient and a pharmaceutically acceptable carrier or salt.

A method for treating an autoimmune neurological disease and/or a neurodegenerative disease is provided. The method includes administering an effective amount of at least one compound having Formula (I), Formula (II) or Formula (III), or its geometric isomer, enantiomer or diastereomer to a subject in need thereof: whereinis a single or double bond, X is NCHor CH, Y is null, O or N, Z is O or N, Ris H, OH, and Ris null, H, C-Calkyl, &#x2014;(C&#x2550;O)-alkyl, &#x2014;(C&#x2550;O)-aryl, &#x2014;(C&#x2550;O)-alkyl-aryl, &#x2014;(C&#x2550;O)-heteroaryl, cycloalkyl or heterocycloalkyl, which optionally substituted by one or more of &#x2014;OH, &#x2014;NO, &#x2014;NH, &#x2014;NRR, carbonyl, alkoxyl, alkyl or &#x2014;OCF, wherein Rand Rindependently are H, alkyl, &#x2014;SOCH, &#x2014;(C&#x2550;O)&#x2014;CHor &#x2014;(C&#x2550;O)&#x2014;NH.

Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage form

A method for treating liver fibrosis. The method includes administering to a subject suffering from liver fibrosis a pharmaceutically active extract obtained from aspecies. Also disclosed is a method for regenerating liver tissue and a method for improving a liver function.

Boehmeria extract and its use in treating liver diseases

Growing community of inventors

Zhubei, Taiwan

Meng-Nan Lin